MALAT1, CCAT1, and PANDAR are lncRNAs that are upregulated in the blood of CRC patients compared to healthy controls, which raises the possibility that they could serve as biomarkers for the prognosis of CRC [68]. This evidence concerns the gene PANDAR and colorectal carcinoma.